Full-Time

Manager/Senior Manager

External Manufacturing

Confirmed live in the last 24 hours

Beam Therapeutics

Beam Therapeutics

501-1,000 employees

Develops precision genetic medicines using base editing

Biotechnology
Healthcare

Senior, Expert

Cambridge, MA, USA

On-site presence (Cambridge MA) preferred 30%.

Category
Genomics
Biology Lab & Research
Biology & Biotech

You match the following Beam Therapeutics's candidate preferences

Employers are more likely to interview you if you match these preferences:

Degree
Experience
Requirements
  • Bachelor of Science and 8+ years experience in biologics manufacturing required.
  • 3+ years experience in a management or technical MSAT position in clinical commercial manufacturing.
  • Experience developing and maintaining manufacturing operations and quality systems required.
  • Experience with managing contract manufacturing organizations required.
  • Experience in commercial manufacturing, supply chain handling, clinical manufacturing and distribution.
  • Knowledge of cGMP requirements is a must.
  • Strong leadership skills with a track record of delivering new products to clinic with external partners.
  • Strong communication skills (written and verbal), including experience presenting in front of multidisciplinary stakeholders.
Responsibilities
  • Management of CMO’s and critical suppliers; including budget planning, tracking, contracts, and manufacturing tactical execution.
  • Establish and foster strong collaborative relationships with external manufacturing partners and service providers.
  • Responsible for developing manufacturing service and supply agreements in close collaboration with Legal, Finance, Procurement, and Quality.
  • Ensure safe and compliant cGMP operations.
  • Establish and maintain detailed project plans; define risks and recommend contingency plans.
  • Align external manufacturing schedules with demand forecast requirements.
  • Ensure product delivery and supply plan is on time and within budget.
  • Resource planning, generating metrics/ KPIs, and presentation of materials for internal stakeholder review.
  • Change owner for manufacturing vendor change notifications; lead or assist with manufacturing deviations, customer complaints, and product failure investigations.
  • Travel for in-person interactions with multiple contract manufacturing entities to ensure production is on plan. 10%
  • On-site presence (Cambridge MA) preferred 30%
  • Supports the development of outsourcing models, vendor evaluation, and CMO selection in close collaboration with key internal stakeholders.
  • Perform other related duties and ad hoc projects as required by position.
Desired Qualifications
  • Cell and Gene Therapy experience preferred
  • Technical understanding of gRNA, mRNA, pDNA
  • Fill finish experience

Beam Therapeutics develops precision genetic medicines using a technique called base editing, which allows for precise modifications to the genetic code to potentially correct mutations that lead to serious diseases. Their primary focus is on treating genetic disorders, such as sickle cell disease, with the aim of providing lifelong cures instead of temporary solutions. The company invests significantly in research and development to create new therapies and generates revenue through partnerships, licensing agreements, and future commercialization of their treatments. Unlike many competitors, Beam Therapeutics emphasizes collaboration with pharmaceutical companies and research institutions, which helps them secure funding and advance their projects. The ultimate goal of Beam Therapeutics is to deliver effective, long-lasting treatments for patients suffering from genetic conditions.

Company Stage

IPO

Total Funding

$215.9M

Headquarters

Cambridge, Massachusetts

Founded

2017

Growth & Insights
Headcount

6 month growth

0%

1 year growth

-1%

2 year growth

0%
Simplify Jobs

Simplify's Take

What believers are saying

  • Base editing technology is gaining traction as a precise genetic correction method.
  • The $250 million deal with Eli Lilly boosts Beam's financial and strategic position.
  • Christi Shaw's appointment to the board brings valuable biotech leadership.

What critics are saying

  • Competition from CRISPR Therapeutics could impact Beam's market share.
  • Recent restructuring and layoffs may lead to operational challenges.
  • New CFO transition might pose financial management challenges.

What makes Beam Therapeutics unique

  • Beam Therapeutics uses base editing, a precise genetic correction method.
  • The company focuses on lifelong cures for genetic disorders like sickle cell disease.
  • Beam's strategic partnerships, like with Eli Lilly, enhance its market position.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Flexible Work Hours